3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Thromboembolism
1
Sarcoma
1
Pulmonary Embolism
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Interventions
Cyclophosphamide
18
fludarabine phosphate
14
Peripheral Blood Stem Cell Transplantation
13
Cyclosporine
12
Whole-Body Irradiation
11
Antilymphocyte Serum
10
fludarabine
9
Exercise
9
Busulfan
9
Mycophenolic Acid
8
Melphalan
8
Dexamethasone
8
Blood Specimen Collection
8
Filgrastim
7
Standard of Care
6
Radiotherapy
6
Behavior Therapy
6
Acupuncture Therapy
6
Therapeutics
5
Specimen Handling
5
Palliative Care
5
Methotrexate
5
Granulocyte Colony-Stimulating Factor
5
Etoposide
5
Educational Status
5
Surveys and Questionnaires
4
Stem Cell Transplantation
4
Psychiatric Rehabilitation
4
Practice Guidelines as Topic
4
Methylprednisolone
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Multiple Myeloma
×
enoxaparin sodium
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled